Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US8598227 | ACTELION | Epoprostenol formulation and method of making thereof |
Feb, 2027
(2 years from now) | |
US8318802 | ACTELION | Epoprostenol formulation and method of making thereof |
Mar, 2027
(2 years from now) |
Market Authorisation Date: 27 June, 2008
Treatment: NA
Dosage: INJECTABLE;INJECTION